Gotham Asset Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Gotham Asset Management’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-29,531	Closed	-$63K	–	1188
2016 Q4	$63K	Sell	29,531 -1,236,590	-98%	-$3.45M	﹤0.01%	918
2016 Q3	$4.24M	Sell	1,266,121 -1,027,402	-45%	-$3.26M	0.06%	384
2016 Q2	$7.2M	Sell	2,293,523 -1,439,156	-39%	-$4.8M	0.09%	334
2016 Q1	$12.4M	Sell	3,732,679 -1,016,011	-21%	-$3.17M	0.14%	255
2015 Q4	$16.8M	Sell	4,748,690 -297,663	-6%	-$1.25M	0.18%	181
2015 Q3	$25.4M	Sell	5,046,353 -2,187,485	-30%	-$12.5M	0.25%	144
2015 Q2	$46.5M	Buy	7,233,838 +3,868,364	+115%	+$25.9M	0.39%	68
2015 Q1	$23.7M	Buy	3,365,474 +3,182,471	+1,739%	+$23M	0.18%	202
2014 Q4	$1.41M	Buy	183,003 +157,006	+604%	+$1.24M	0.01%	563
2014 Q3	$194K	Sell	25,997 -763,807	-97%	-$7.09M	﹤0.01%	943
2014 Q2	$7.64M	Sell	789,804 -875,739	-53%	-$7.81M	0.1%	309
2014 Q1	$13.8M	Sell	1,665,543 -1,678,430	-50%	-$14.4M	0.21%	167
2013 Q4	$28.2M	Buy	3,343,973 +453,409	+16%	+$3.82M	0.67%	2
2013 Q3	$23M	Buy	2,890,564 +575,183	+25%	+$4.62M	0.75%	6
2013 Q2	$17.9M	Buy	+2,315,381	New	+$18.1M	0.77%	7

Other funds holding PDLI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Gotham Asset Management's PDLI Position: Q1 2017 in Review

Gotham Asset Management sold out of PDL BioPharma, Inc. (PDLI) in Q1 2017, closing a stake of 29,531 shares — an estimated $63K sold.

Gotham Asset Management first reported a position in PDLI in Q2 2013 and held it in 15 quarters. The position peaked at $46.5M in Q2 2015. 174 funds tracked by Wall St. Rank hold PDLI as of Q1 2017.

Gotham Asset Management reported no remaining PDL BioPharma, Inc. position as of Q1 2017 after selling out during the quarter.
Gotham Asset Management sold 29,531 PDL BioPharma, Inc. shares in Q1 2017, an estimated $63K.
Gotham Asset Management first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 15 quarters.
Gotham Asset Management's PDL BioPharma, Inc. position peaked at $46.5M in Q2 2015.
174 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2017.

Based on Gotham Asset Management's 13F filing for Q1 2017, filed 15 May 2017.